Company Financials: Acadia Pharmaceuticals Inc.

Introduction

The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. THIS PRODUCT HAS BEEN DESIGNED FOR DELIVERY IN A DATAPACK FORMAT (.XLS). PLEASE SELECT THE DATAPACK OPTION FROM THE DOWNLOAD MENU.

Scope

*Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation

*Provides key ratios

*Includes information on revenue distribution by business segments and geographies

Highlights

ACADIA Pharmaceuticals (ACADIA) is a biopharmaceutical company engaged in drug discovery and clinical development of novel treatments for central nervous system disorders.

The company is focused on developing a portfolio consisting of product candidates including pimavanserin, which is in Phase III development for the treatment of Parkinson's disease psychosis in collaboration with Biovail.

It also has a product candidate in Phase II for chronic pain and a product candidate in Phase I for glaucoma, both in collaboration with Allergan, and additional programs in IND-track development.

Reasons to Purchase

*Access important financial information and analysis on the company in a single datapack

*Understand the financial evolution of the company over the last five years

*Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization


Report Highlights

[Studien Infos ausblenden]

#NV
[Inhaltsverzeichnis ausblenden]